{"disease":{"id":"tuberculosis-drug-susceptible","name":"tuberculosis drug susceptible"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07129629","title":"Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}